... filed a patent infringement suit against Watson Pharmaceuticals, alleging it had infringed on its patent for the contraceptive Seasonique. ...
based Watson said it believes it may be the first to file this type of application for Seasonique, and it may be entitled to 180 days of generic market ...
22 issued a patent for Seasonique, which expires in 2024. That same day, Watson notified Barr that it had filed an FDA abbreviated new drug application to ...
N: Quote, Profile, Research), alleging infringement of the patent for Seasonique, its extended-cycle oral contraceptive product. Barr said its unit Duramed ...
Duramed's patent on Seasonique is due to expire on Jan. 30, 2024. In addition, the company also has a three-year new product exclusivity for its Seasonique ...
The Company's SEASONIQUE Patent No. 7320969 is due to expire on January 30, 2024. In addition to the patent, the Company also has 3-year New Product ...
Barr also has new-product regulatory exclusivity for Seasonique until 2009. Barr shares tumbled $1.88, or 3.8 percent, to $47.59 in morning trading. ...
TO), a Canadian pharmaceutical company, said on 29 February that a new drug submission for SEASONIQUE has been filed with the Therapeutic Products ...
... filed a lawsuit against Watson Pharmaceuticals Inc., a branded and generic drug company, for infringement of its patent on Seasonique, a birth-control pill.
Seasonique is indicated for the prevention of pregnancy. 3/4/2008 5:06:59 PM DivX, Inc. (DIVX) announced that its Board has authorized the company to ...